Pacira BioSciences, Inc.
Status: Publicly traded
Direct answer
Pacira BioSciences, Inc. is publicly traded on NASDAQ under the ticker PCRX.
Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers the iovera system, a...
Can you invest in Pacira BioSciences, Inc.?
Yes. Pacira BioSciences, Inc. is publicly traded on NASDAQ under the ticker PCRX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Pacira BioSciences, Inc.
Detailed equity research is provided by MarketSnap.